Gemcitabine/VinorelbineLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2037卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71883-4

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：190 / 190

相关论文

共 50 条

[41] Cisplatin/gemcitabine/pirarubicinLack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 125 - 125
[42] Carboplatin/gemcitabine/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1926 (1) : 151 - 151
[43] Cisplatin/gemcitabine/pemetrexedLack of efficacy: case report
Reactions Weekly, 2021, 1857 (1) : 114 - 114
[44] Docetaxel/gemcitabine/paclitaxelLack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 206 - 206
[45] Cisplatin/Gemcitabine/RituximabLack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 134 - 134
[46] Carboplatin/gemcitabine/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1931 (1) : 167 - 167
[47] Gemcitabine/ifosfamide/pirarubicinLack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 203 - 203
[48] Cisplatin/gemcitabine/paclitaxelLack of efficacy: case report
Reactions Weekly, 2022, 1914 (1) : 163 - 163
[49] Nimotuzumab/temozolomide/vinorelbineLack of efficacy: 7 case reports
Reactions Weekly, 2025, 2044 (1) : 285 - 285
[50] Cisplatin/gemcitabine/pembrolizumabCandidaemia and lack of efficacy: case report
Reactions Weekly, 2023, 1946 (1) : 168 - 168

← 1 2 3 4 5 →